A rationale for the treatment of short stature in children with the combination of recombinant human growth hormone (rhGH) and recombinant human insulin-like growth factor-I (rhIGF-I)
Both rhGH and rhIGF-I are signaling molecules with the capacity to restore the rate of growth in certain subsets of slowly growing children. In some instances, heights attained at or near the time of cessation of linear growth are indistinguishable from the height distribution of the community as a...
Saved in:
| Published in | Growth hormone & IGF research Vol. 52; p. 101318 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
Scotland
Elsevier Ltd
01.06.2020
|
| Online Access | Get full text |
Cover
Loading…
| Abstract | Both rhGH and rhIGF-I are signaling molecules with the capacity to restore the rate of growth in certain subsets of slowly growing children. In some instances, heights attained at or near the time of cessation of linear growth are indistinguishable from the height distribution of the community as a whole or from the height distribution expected based on the heights of biological parents. The GH: IGF-I signaling system is sequential, forming a continuous loop wherein GH will stimulate production of IGF-I and IGF-I will inhibit production of GH. This feature suggests that a deficiency of GH will be accompanied by a deficiency of IGF-I and that treatment of GH deficiency with rhGH will restore IGF-I and the subnormal growth of combined GH: IGF-I deficiency. Although logical, this proposition is not always true. rhGH and rhIGF-I are distinct polypeptides, with distinct cell surface receptors and distinct intracellular signaling pathways both capable of amplifying distinct, yet overlapping, patterns of gene replication, protein synthesis and metabolic activities. These features suggest that neither treatment with rhGH nor rhIGF-I alone will invariably recapitulate the combined activities of the GH: IGF-I system, At the present time, this proposition appears both logical and true. The possibility that combined rhGH and rhIGF-I treatment can accomplish that which neither monotherapy can has been examined in gene knock-out experiments in animals and direct comparisons of GH, IGF-I and combined GH: IGF- treatments in animals and in children with short stature, normal GH and low IGF-I (primary IGF-I deficiency). In these experimental models, the growth rates with combined rhGH and rhIGF-I treatment exceed those of either monotherapy. The extent to which this proposition can be generalized to various short stature populations remains to be determined. |
|---|---|
| AbstractList | Both rhGH and rhIGF-I are signaling molecules with the capacity to restore the rate of growth in certain subsets of slowly growing children. In some instances, heights attained at or near the time of cessation of linear growth are indistinguishable from the height distribution of the community as a whole or from the height distribution expected based on the heights of biological parents. The GH: IGF-I signaling system is sequential, forming a continuous loop wherein GH will stimulate production of IGF-I and IGF-I will inhibit production of GH. This feature suggests that a deficiency of GH will be accompanied by a deficiency of IGF-I and that treatment of GH deficiency with rhGH will restore IGF-I and the subnormal growth of combined GH: IGF-I deficiency. Although logical, this proposition is not always true. rhGH and rhIGF-I are distinct polypeptides, with distinct cell surface receptors and distinct intracellular signaling pathways both capable of amplifying distinct, yet overlapping, patterns of gene replication, protein synthesis and metabolic activities. These features suggest that neither treatment with rhGH nor rhIGF-I alone will invariably recapitulate the combined activities of the GH: IGF-I system, At the present time, this proposition appears both logical and true. The possibility that combined rhGH and rhIGF-I treatment can accomplish that which neither monotherapy can has been examined in gene knock-out experiments in animals and direct comparisons of GH, IGF-I and combined GH: IGF- treatments in animals and in children with short stature, normal GH and low IGF-I (primary IGF-I deficiency). In these experimental models, the growth rates with combined rhGH and rhIGF-I treatment exceed those of either monotherapy. The extent to which this proposition can be generalized to various short stature populations remains to be determined. Both rhGH and rhIGF-I are signaling molecules with the capacity to restore the rate of growth in certain subsets of slowly growing children. In some instances, heights attained at or near the time of cessation of linear growth are indistinguishable from the height distribution of the community as a whole or from the height distribution expected based on the heights of biological parents. The GH: IGF-I signaling system is sequential, forming a continuous loop wherein GH will stimulate production of IGF-I and IGF-I will inhibit production of GH. This feature suggests that a deficiency of GH will be accompanied by a deficiency of IGF-I and that treatment of GH deficiency with rhGH will restore IGF-I and the subnormal growth of combined GH: IGF-I deficiency. Although logical, this proposition is not always true. rhGH and rhIGF-I are distinct polypeptides, with distinct cell surface receptors and distinct intracellular signaling pathways both capable of amplifying distinct, yet overlapping, patterns of gene replication, protein synthesis and metabolic activities. These features suggest that neither treatment with rhGH nor rhIGF-I alone will invariably recapitulate the combined activities of the GH: IGF-I system, At the present time, this proposition appears both logical and true. The possibility that combined rhGH and rhIGF-I treatment can accomplish that which neither monotherapy can has been examined in gene knock-out experiments in animals and direct comparisons of GH, IGF-I and combined GH: IGF- treatments in animals and in children with short stature, normal GH and low IGF-I (primary IGF-I deficiency). In these experimental models, the growth rates with combined rhGH and rhIGF-I treatment exceed those of either monotherapy. The extent to which this proposition can be generalized to various short stature populations remains to be determined.Both rhGH and rhIGF-I are signaling molecules with the capacity to restore the rate of growth in certain subsets of slowly growing children. In some instances, heights attained at or near the time of cessation of linear growth are indistinguishable from the height distribution of the community as a whole or from the height distribution expected based on the heights of biological parents. The GH: IGF-I signaling system is sequential, forming a continuous loop wherein GH will stimulate production of IGF-I and IGF-I will inhibit production of GH. This feature suggests that a deficiency of GH will be accompanied by a deficiency of IGF-I and that treatment of GH deficiency with rhGH will restore IGF-I and the subnormal growth of combined GH: IGF-I deficiency. Although logical, this proposition is not always true. rhGH and rhIGF-I are distinct polypeptides, with distinct cell surface receptors and distinct intracellular signaling pathways both capable of amplifying distinct, yet overlapping, patterns of gene replication, protein synthesis and metabolic activities. These features suggest that neither treatment with rhGH nor rhIGF-I alone will invariably recapitulate the combined activities of the GH: IGF-I system, At the present time, this proposition appears both logical and true. The possibility that combined rhGH and rhIGF-I treatment can accomplish that which neither monotherapy can has been examined in gene knock-out experiments in animals and direct comparisons of GH, IGF-I and combined GH: IGF- treatments in animals and in children with short stature, normal GH and low IGF-I (primary IGF-I deficiency). In these experimental models, the growth rates with combined rhGH and rhIGF-I treatment exceed those of either monotherapy. The extent to which this proposition can be generalized to various short stature populations remains to be determined. |
| ArticleNumber | 101318 |
| Author | Bright, George M. Fierro-Renoy, Juan Francisco |
| Author_xml | – sequence: 1 givenname: George M. surname: Bright fullname: Bright, George M. email: gmb@pendoconsult.com organization: Seabrook, South Carolina, United States – sequence: 2 givenname: Juan Francisco surname: Fierro-Renoy fullname: Fierro-Renoy, Juan Francisco organization: Department of Endocrinology and Diabetology, Universidad Central del Ecuador, Quito, Ecuador |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32252003$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkc1u3CAYRVGUKH_NC2RRsUwWnmAYG0_VTRQ1k5EiddOuEcYfMRMMKeBGebK-XvH8bKIqXYHQOVfi3jN06LwDhC5LMitJWd-sZ0-9CTNK6OaBlc0BOi0rRgtKWXOY72RRFzXj8xN0FuOaELJgzfwYnTBKK0oIO0V_bnGQyXgnLWDtA0494BRApgFcwl7j2PuQcEwyjQGwcVj1xnYBHH41qd_wyg-tcZuYyQiwe8gB_ThIh5-Cf81sThryF_BV6JcP11i67h-scXG0xhXWPMNe1FIlH4rVZK6W98Xq-hM60tJGuNid5-jn_bcfdw_F4_fl6u72sVBzwlNRyQraLv9WgW5qpqjknJK2IYozXVWw0EzLtio1562SnWp4qRSjHW1ydUA6do6utrkvwf8aISYxmKjAWunAj1HkojmtSUmqjH7eoWM7QCdeghlkeBP7sjPQbAEVfIwBtFAmbVpLQRorSiKmXcVaTLuKaVex3TWr9J26T_9Q-rqVIBf020AQURlwCjqTa0-i8-Zj_cs7XeVdjJL2Gd7-J_8FW4rR2g |
| CitedBy_id | crossref_primary_10_3389_fendo_2023_1141039 crossref_primary_10_1186_s13048_024_01536_8 crossref_primary_10_3390_ijms242316608 crossref_primary_10_1096_fj_202401298R crossref_primary_10_1159_000540053 |
| Cites_doi | 10.1210/jc.2013-1437 10.1542/peds.104.S5.1000 10.1038/281544a0 10.1016/j.ghir.2016.01.002 10.1056/NEJMoa010107 10.1371/journal.pbio.2005263 10.1159/000452150 10.1210/er.2008-0027 10.1210/endo.137.5.8612531 10.1210/jcem.87.1.8150 10.1016/S0021-9258(19)89179-2 10.1210/jc.2009-1471 10.1159/000374114 10.1007/BF03021409 10.1210/jc.2006-1610 10.1073/pnas.86.8.2868 10.1210/jc.2007-0204 10.1159/000371799 10.1210/jcem.84.12.6255 10.1530/EC-17-0007 10.1136/bmj.325.7355.70 10.1210/jc.2004-1254 10.1006/dbio.2000.9975 10.1210/jcem.84.4.5634 10.1530/EJE-08-0703 10.1210/jcem-65-5-1075 10.1210/jc.2005-2284 10.1056/NEJMcp1213178 10.1111/j.1463-1326.2006.00591.x 10.1016/S0140-6736(06)69205-2 10.1210/edrv-15-3-369 10.1016/S0021-9258(19)52796-X 10.1210/endo-124-5-2519 |
| ContentType | Journal Article |
| Copyright | 2020 Copyright © 2020. Published by Elsevier Ltd. |
| Copyright_xml | – notice: 2020 – notice: Copyright © 2020. Published by Elsevier Ltd. |
| DBID | AAYXX CITATION NPM 7X8 |
| DOI | 10.1016/j.ghir.2020.101318 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Anatomy & Physiology |
| EISSN | 1532-2238 |
| ExternalDocumentID | 32252003 10_1016_j_ghir_2020_101318 S1096637420300277 |
| Genre | Journal Article |
| GroupedDBID | --- --K --M .1- .FO .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABGSF ABJNI ABMAC ABMZM ABUDA ABWVN ABXDB ACDAQ ACGFS ACIEU ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADMUD ADNMO ADUVX AEBSH AEHWI AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGHFR AGQPQ AGRDE AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DU5 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-Q GBLVA HVGLF HZ~ IHE J1W KOM M41 MO0 N9A O-L O9- OAUVE OB0 ON- OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SDF SDG SDP SEL SES SEW SPCBC SSH SSU SSZ T5K Z5R ~G- AACTN AAIAV ABLVK ABYKQ AFCTW AFKWA AJBFU AJOXV AMFUW DOVZS EFLBG LCYCR RIG AAYXX AGRNS CITATION NPM 7X8 |
| ID | FETCH-LOGICAL-c407t-5a5ebd225cef863c2a7720b80c73f55e9f3fab51f77bcadc871cc32d28096e0d3 |
| IEDL.DBID | .~1 |
| ISSN | 1096-6374 1532-2238 |
| IngestDate | Fri Jul 11 12:22:41 EDT 2025 Wed Feb 19 02:30:57 EST 2025 Tue Jul 01 01:22:40 EDT 2025 Thu Apr 24 23:05:41 EDT 2025 Fri Feb 23 02:47:34 EST 2024 Tue Aug 26 20:25:26 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Language | English |
| License | Copyright © 2020. Published by Elsevier Ltd. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c407t-5a5ebd225cef863c2a7720b80c73f55e9f3fab51f77bcadc871cc32d28096e0d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| PMID | 32252003 |
| PQID | 2387260105 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2387260105 pubmed_primary_32252003 crossref_citationtrail_10_1016_j_ghir_2020_101318 crossref_primary_10_1016_j_ghir_2020_101318 elsevier_sciencedirect_doi_10_1016_j_ghir_2020_101318 elsevier_clinicalkey_doi_10_1016_j_ghir_2020_101318 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | June 2020 2020-06-00 2020-Jun 20200601 |
| PublicationDateYYYYMMDD | 2020-06-01 |
| PublicationDate_xml | – month: 06 year: 2020 text: June 2020 |
| PublicationDecade | 2020 |
| PublicationPlace | Scotland |
| PublicationPlace_xml | – name: Scotland |
| PublicationTitle | Growth hormone & IGF research |
| PublicationTitleAlternate | Growth Horm IGF Res |
| PublicationYear | 2020 |
| Publisher | Elsevier Ltd |
| Publisher_xml | – name: Elsevier Ltd |
| References | Ranke, Lindberg, on behalf of the KIGS International Board (bb0210) 2010; 95 Cohen, Bright, Rogol, Kappelgaard (bb0200) 2002; 87 Dv, Heyneker (bb0005) 1979; 281 Rosenfeld, Rosenbloom (bb0070) 1994; 15 Chernausek, Backeljauw, Frane, Kuntze (bb0180) 2007; 92 session of American Associations of Anatomists, Philadelphia, March 1921. Abstract # 38. Mauras, O’Brien, Welch, Rini, Helgeson, Vierra, Yergey (bb0130) 2000; 85 Fielder, Mortensen, Mallet, Carlsson, Baxter, Clark (bb0170) 1996; 137 Lui, Jee, Garrison, Iben, Yue, Ad, Nguyen, Kikani, Wakabayashi, Baron (bb0190) 2018; 16 Moller, Jorgensen (bb0095) 2009; 30 Grimber, DiVall, Polychronakos (bb0040) 2016; 86 Walenkamp, Pereira, Hilforst-Hofstee, Vaaaaan Dorn, Chen, Mohan, Denley, Forbes, Van Duyvenvoorde, Van Thiel, Sluimers, Bax, JAPM, Breuning, Romjin, Wit (bb0140) 2005; 90 Backeljauw, Miller, Dutailly (bb0045) 2015; 83 Abuzzahab, Schneider, Goddard, Grigorescu, Lautier, Keller, Kiess, Klammt, Kratsch, Osgood, Pfaffle, Raile, Seidel, Smith, Chernausek SD for the IUGR study group (bb0145) 2003; 349 Reiter, Price, Wilton (bb0010) 2006; 91 Mauras, Martinez, Rini, Guevara-Aguirre (bb0135) 2000; 85 Hoybye, Pfeiffer, Ferone, Christiansen, Gilfoyle, Christoffersen, Mortensen, Leff, Beckert (bb0115) 2017; 6 Cohen, Rogol, Howard, Bright, Kappelgaard, Rosenfeld (bb0195) 2007; 92 Skottner, Clark, Fryklund, Robinson (bb0175) 1989; 124 Rosenfeld, Albertsson-Wikland, Cassorla, Frasier, Hasegawa, Hintz, LaFRanchi, Lippe, Loriaux, Melmed, Preece, Ranke, Reiter, Rogol, Underwood, Werther (bb0185) 1995; 80 Clark, Mortensen, Mallet (bb0035) 1995; 3 Vaccarello, Diamond, Guevarra-Aguirre, Rosenbloom, Fielder, Gargosky, Cohen, Wilson, Rosenfeld (bb0125) 1993; 77 Frindik, Baptista (bb0060) 1999; 104 Evans HM, Long JA. The effect of anterior lobe administered intraperitoneally upon growth, maturity and oestrous cycles of the rat. 37 Peter, Savoy, H-J, Juhassz, Bidlingmaier, Saenger (bb0110) 2009; 160 Yuen, Conway, Popovic, Merriam, Bailey, Hamrahian, Biller, Kipnes, Moore, Humphriss, Bright, Cleland (bb0105) 2013; 98 Bright (bb0025) 2016; 28 Guler, Schmid, Froesch (bb0155) 1989; 86 Laron (bb0065) 1999; 84 Li, Evans, Simpson (bb0080) 1945; xxx Lupu, Terwilliger, Lee, Segre, Efstratiatis (bb0165) 2001; 229 Rasmussen, Christiansen, Madsen (bb0100) 2015; 7 Yuen, Dunger (bb0150) 2007; 9 Midyett, Rogol, Van Meter, Frane, Bright (bb0160) 2011; 10 Rosenbloom (bb0030) 2006; 368 Salmon, Daughaday (bb0085) 1957; 49 Daughaday, Hall, Salmon, Van den Brande, Van Wyk (bb0090) 1987; 65 Ranke, Lindberg, Chatelain, Wilton, Cutfield, Albertsson-Wikland, Price (bb0205) 1999; 84 Jones John, Clemmons (bb0215) 1995; 16 Allen, Cuttler (bb0055) 2013; 368 Giustina, Veldhuis (bb0120) 1998; 19 Rosenfeld (bb0050) 2015; 83 Carel, Ecoss, Nicolino (bb0015) 2002; 325 Rotwein, Pollok, Didier (bb0020) 1986; 261 Skottner (10.1016/j.ghir.2020.101318_bb0175) 1989; 124 Rotwein (10.1016/j.ghir.2020.101318_bb0020) 1986; 261 Daughaday (10.1016/j.ghir.2020.101318_bb0090) 1987; 65 Hoybye (10.1016/j.ghir.2020.101318_bb0115) 2017; 6 Dv (10.1016/j.ghir.2020.101318_bb0005) 1979; 281 Cohen (10.1016/j.ghir.2020.101318_bb0200) 2002; 87 Backeljauw (10.1016/j.ghir.2020.101318_bb0045) 2015; 83 Salmon (10.1016/j.ghir.2020.101318_bb0085) 1957; 49 Lui (10.1016/j.ghir.2020.101318_bb0190) 2018; 16 Rosenfeld (10.1016/j.ghir.2020.101318_bb0050) 2015; 83 Rasmussen (10.1016/j.ghir.2020.101318_bb0100) 2015; 7 Fielder (10.1016/j.ghir.2020.101318_bb0170) 1996; 137 Reiter (10.1016/j.ghir.2020.101318_bb0010) 2006; 91 Rosenfeld (10.1016/j.ghir.2020.101318_bb0070) 1994; 15 Grimber (10.1016/j.ghir.2020.101318_bb0040) 2016; 86 Ranke (10.1016/j.ghir.2020.101318_bb0205) 1999; 84 Walenkamp (10.1016/j.ghir.2020.101318_bb0140) 2005; 90 Rosenfeld (10.1016/j.ghir.2020.101318_bb0185) 1995; 80 Cohen (10.1016/j.ghir.2020.101318_bb0195) 2007; 92 Carel (10.1016/j.ghir.2020.101318_bb0015) 2002; 325 Bright (10.1016/j.ghir.2020.101318_bb0025) 2016; 28 Yuen (10.1016/j.ghir.2020.101318_bb0105) 2013; 98 Allen (10.1016/j.ghir.2020.101318_bb0055) 2013; 368 Laron (10.1016/j.ghir.2020.101318_bb0065) 1999; 84 Vaccarello (10.1016/j.ghir.2020.101318_bb0125) 1993; 77 Lupu (10.1016/j.ghir.2020.101318_bb0165) 2001; 229 Mauras (10.1016/j.ghir.2020.101318_bb0130) 2000; 85 Clark (10.1016/j.ghir.2020.101318_bb0035) 1995; 3 Frindik (10.1016/j.ghir.2020.101318_bb0060) 1999; 104 Yuen (10.1016/j.ghir.2020.101318_bb0150) 2007; 9 Midyett (10.1016/j.ghir.2020.101318_bb0160) 2011; 10 Abuzzahab (10.1016/j.ghir.2020.101318_bb0145) 2003; 349 Ranke (10.1016/j.ghir.2020.101318_bb0210) 2010; 95 Li (10.1016/j.ghir.2020.101318_bb0080) 1945; xxx Jones John (10.1016/j.ghir.2020.101318_bb0215) 1995; 16 Giustina (10.1016/j.ghir.2020.101318_bb0120) 1998; 19 Guler (10.1016/j.ghir.2020.101318_bb0155) 1989; 86 Mauras (10.1016/j.ghir.2020.101318_bb0135) 2000; 85 10.1016/j.ghir.2020.101318_bb0075 Chernausek (10.1016/j.ghir.2020.101318_bb0180) 2007; 92 Moller (10.1016/j.ghir.2020.101318_bb0095) 2009; 30 Rosenbloom (10.1016/j.ghir.2020.101318_bb0030) 2006; 368 Peter (10.1016/j.ghir.2020.101318_bb0110) 2009; 160 |
| References_xml | – volume: 281 start-page: 544 year: 1979 end-page: 548 ident: bb0005 article-title: Hozumi T. et al. direct expression in e. coli of a DNA sequence coding for human growth hormone publication-title: Nature – volume: 124 start-page: 2519 year: 1989 end-page: 2526 ident: bb0175 article-title: Growth responses in a mutant dwarf rat to human growth hormone and recombinant human insulin-like growth factor-I publication-title: Endocrinology – volume: 84 start-page: 1174 year: 1999 end-page: 1183 ident: bb0205 article-title: Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency publication-title: J. Clin. Endocrinol. Metab. – volume: 83 start-page: 268 year: 2015 ident: bb0045 article-title: Recombinant human growth hormone plus recombinant human insulin-like growth factor I co-administration therapy in short children with low insulin-like growth factor I and growth hormone sufficiency: results from a randomized multicenter, open-label, parallel-group, active treatment-controlled trial publication-title: Horm Res in Paediatr – volume: 15 start-page: 369 year: 1994 end-page: 390 ident: bb0070 article-title: Guevarra-Aguirre J growth hormone (GH) insensitivity due to primary GH receptor deficiency publication-title: Endocr. Rev. – volume: 3 start-page: 297 year: 1995 end-page: 304 ident: bb0035 article-title: Insulin-like growth factor 1 and growth hormone have distinct and overlapping anabolic effects in GH deficient rats publication-title: Endocrine – volume: 9 start-page: 11 year: 2007 end-page: 22 ident: bb0150 article-title: Therapeutic aspects of growth hormone and insulin-like growth factor_I treatment on visceral fat and insulin sensitivity in adults diabetes publication-title: Obes. Metab. – volume: 92 start-page: 902 year: 2007 end-page: 910 ident: bb0180 article-title: Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children wit severe IGF-I deficiency due to growth hormone insensitivity publication-title: J. Clin. Endocrinol. Metab. – volume: 77 start-page: 273 year: 1993 end-page: 280 ident: bb0125 article-title: Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome publication-title: J. Clin. Endocrinol. Metab. – volume: 85 start-page: 1686 year: 2000 end-page: 1694 ident: bb0130 article-title: Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid and calcium metabolism publication-title: J. Clin. Endocrinol. Metab. – volume: 7 start-page: 34 year: 2015 end-page: 38 ident: bb0100 article-title: Growth hormone bioavailability, insulin-like growth factor-I and IGF-binding protein 3 release in Japanese and Caucasian subjects publication-title: Bioequivalence and Bioavailabilty – volume: 86 start-page: 361 year: 2016 end-page: 397 ident: bb0040 article-title: Guidelines for growth hormone and insulin-like growth factor 1 treatment in children and adolescents: growth hormone deficiency, idiopathic short stature and primary insulin-like growth factor-I deficiency publication-title: Horm Res in Paediatr – volume: 325 start-page: 70 year: 2002 ident: bb0015 article-title: Adult height after long-term treatment with recombinant growth hormone for idiopathic isolated growth hormone deficiency: observational follow-up study of the French population based registry publication-title: BMJ – volume: 16 start-page: 3 year: 1995 end-page: 34 ident: bb0215 article-title: Insulin-like growth factors and their binding proteins: biological actions publication-title: Endocr. Rev. – volume: 91 start-page: 2047 year: 2006 end-page: 2054 ident: bb0010 article-title: Effect of growth hormone treatment in the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database publication-title: J. Clin. Endocrinol. Metab. – volume: 83 start-page: 280 year: 2015 end-page: 281 ident: bb0050 article-title: How aggressively should we treat short stature? publication-title: Horm Res Paediatr – volume: 104 start-page: 1000 year: 1999 end-page: 1004 ident: bb0060 article-title: Adult height in growth hormone deficiency: historical perspective and examples from the national cooperative growth study publication-title: Pediatrics – volume: 160 start-page: 349 year: 2009 end-page: 355 ident: bb0110 article-title: Pharmacokinetic and pharmacodynamic profile of a new sustained release GH formulation, LB3002, in children with GH deficiency publication-title: Eur. J. Endocrinol. – volume: 49 start-page: 825 year: 1957 end-page: 836 ident: bb0085 article-title: A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro publication-title: J. Lab. Clin. Med. – reference: session of American Associations of Anatomists, Philadelphia, March 1921. Abstract # 38. – volume: 86 start-page: 2868 year: 1989 end-page: 2872 ident: bb0155 article-title: Effects of insulin-like growth factor-I on insulin secretion and renal function in normal human subjects publication-title: Proc Natl Acad Sci USA – reference: Evans HM, Long JA. The effect of anterior lobe administered intraperitoneally upon growth, maturity and oestrous cycles of the rat. 37 – volume: 98 start-page: 2595 year: 2013 end-page: 2603 ident: bb0105 article-title: A long-acting growth hormone with delayed clearance (VRS-317): results of a double-blind, placebo controlled, single ascending dose study in growth hormone deficient adults publication-title: J. Clin. Endocrinol. Metab. – volume: 6 start-page: 129 year: 2017 end-page: 138 ident: bb0115 article-title: A phase 2 trial of long-acting growth hormne in adult GH deficiency publication-title: Endocrine Connections – volume: 368 start-page: 1220 year: 2013 end-page: 1228 ident: bb0055 article-title: Short stature in childhood- challenges and choices publication-title: N. Engl. J. Med. – volume: 10 start-page: 611 year: 2011 end-page: 619 ident: bb0160 article-title: Recombinant insulin-like growth factor-I (IGF_I) treatment in short children with low IGF-I levels: First year results from a randomized clinical trial publication-title: J Clin Endocrinol Metab – volume: 95 start-page: 1229 year: 2010 end-page: 1237 ident: bb0210 article-title: Observed and predicted growth responses in prepubertal children with growth disorders: guidance of growth hormone treatment by empirical variables publication-title: J. Clin. Endocrinol. Metab. – volume: 30 start-page: 152 year: 2009 end-page: 177 ident: bb0095 article-title: Effects of growth hormone on glucose, lipid and protein metabolism in human subjects publication-title: Endocr. Rev. – volume: 87 start-page: 90 year: 2002 end-page: 98 ident: bb0200 article-title: Effects of dose and gender on the growth and growth factor response to gh in GH deficient children: implications for efficacy and safety publication-title: J. Clin. Endocrinol. Metab. – volume: 92 start-page: 2480 year: 2007 end-page: 2486 ident: bb0195 article-title: on behalf of the American Norditropin Study Group publication-title: J Clin Endocrinol Metab – volume: 349 start-page: 2211 year: 2003 end-page: 2222 ident: bb0145 article-title: IGF_I receptor mutations resulting in intrauterine and postnatal growth retardations publication-title: N. Engl. J. Med. – volume: 261 start-page: 4828 year: 1986 end-page: 4832 ident: bb0020 article-title: Organization and sequence of the insulin-like growth factor 1 gene publication-title: J. Biol. Chem. – volume: 229 start-page: 141 year: 2001 end-page: 162 ident: bb0165 article-title: Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth publication-title: Dev. Biol. – volume: 368 start-page: 612 year: 2006 end-page: 616 ident: bb0030 article-title: Is there a role for recombinant insulin-like growth factor 1 in the treatment of idiopathic short stature? publication-title: Lancet – volume: 84 start-page: 4397 year: 1999 end-page: 4404 ident: bb0065 article-title: The essential role of IGF-I: lessons from the long-term study and treatment of children and adults with Laron syndrome publication-title: J. Clin. Endocrinol. Metab. – volume: 80 start-page: 1532 year: 1995 end-page: 1540 ident: bb0185 article-title: Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited publication-title: J. Clin. Endocrinol. Metab. – volume: 19 start-page: 717 year: 1998 end-page: 797 ident: bb0120 article-title: Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human publication-title: Endocr. Rev. – volume: xxx start-page: 353 year: 1945 end-page: 366 ident: bb0080 article-title: Isolation and properties of the anterior hypophyseal growth hormone publication-title: J. Biol Chem – volume: 137 start-page: 1913 year: 1996 end-page: 1920 ident: bb0170 article-title: Differential long-term effects of insulin-like growth factor-I (IGF-I), growth hormone (GH) and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats publication-title: Endocrinology – volume: 65 start-page: 1075 year: 1987 end-page: 1076 ident: bb0090 article-title: On the nomenclature of the somatomedins and insulin-like growth factors publication-title: J. Clin. Endocrinol. Metab. – volume: 90 start-page: 2855 year: 2005 end-page: 2864 ident: bb0140 article-title: Homozygous and Heterozygous expression of a novel insulin-like growth factor-I mutation publication-title: J Clin Endocrinol Metab – volume: 16 start-page: 7 year: 2018 ident: bb0190 article-title: Differential aging of the growth plate cartilage underlies differences in bone length and thus helps determine skeletal proportions publication-title: PLoS Biol – volume: 28 start-page: 62 year: 2016 end-page: 65 ident: bb0025 article-title: Recombinant IGF-1: past, present and future publication-title: Growth Hormone and IGF Research – volume: 85 start-page: 3036 year: 2000 end-page: 3042 ident: bb0135 article-title: Recombinant human insulin-like growth factor-I has significant anabolic effect in adults with growth hormone receptor deficiency: studies on protein, glucose and lipid metabolism publication-title: J. Clin. Endocrinol. Metab. – volume: 98 start-page: 2595 year: 2013 ident: 10.1016/j.ghir.2020.101318_bb0105 article-title: A long-acting growth hormone with delayed clearance (VRS-317): results of a double-blind, placebo controlled, single ascending dose study in growth hormone deficient adults publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2013-1437 – volume: 104 start-page: 1000 year: 1999 ident: 10.1016/j.ghir.2020.101318_bb0060 article-title: Adult height in growth hormone deficiency: historical perspective and examples from the national cooperative growth study publication-title: Pediatrics doi: 10.1542/peds.104.S5.1000 – volume: 281 start-page: 544 year: 1979 ident: 10.1016/j.ghir.2020.101318_bb0005 article-title: Hozumi T. et al. direct expression in e. coli of a DNA sequence coding for human growth hormone publication-title: Nature doi: 10.1038/281544a0 – ident: 10.1016/j.ghir.2020.101318_bb0075 – volume: 80 start-page: 1532 year: 1995 ident: 10.1016/j.ghir.2020.101318_bb0185 article-title: Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited publication-title: J. Clin. Endocrinol. Metab. – volume: 28 start-page: 62 year: 2016 ident: 10.1016/j.ghir.2020.101318_bb0025 article-title: Recombinant IGF-1: past, present and future publication-title: Growth Hormone and IGF Research doi: 10.1016/j.ghir.2016.01.002 – volume: 349 start-page: 2211 year: 2003 ident: 10.1016/j.ghir.2020.101318_bb0145 article-title: IGF_I receptor mutations resulting in intrauterine and postnatal growth retardations publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa010107 – volume: 16 start-page: 7 year: 2018 ident: 10.1016/j.ghir.2020.101318_bb0190 article-title: Differential aging of the growth plate cartilage underlies differences in bone length and thus helps determine skeletal proportions publication-title: PLoS Biol doi: 10.1371/journal.pbio.2005263 – volume: 85 start-page: 3036 year: 2000 ident: 10.1016/j.ghir.2020.101318_bb0135 article-title: Recombinant human insulin-like growth factor-I has significant anabolic effect in adults with growth hormone receptor deficiency: studies on protein, glucose and lipid metabolism publication-title: J. Clin. Endocrinol. Metab. – volume: 86 start-page: 361 year: 2016 ident: 10.1016/j.ghir.2020.101318_bb0040 article-title: Guidelines for growth hormone and insulin-like growth factor 1 treatment in children and adolescents: growth hormone deficiency, idiopathic short stature and primary insulin-like growth factor-I deficiency publication-title: Horm Res in Paediatr doi: 10.1159/000452150 – volume: 30 start-page: 152 year: 2009 ident: 10.1016/j.ghir.2020.101318_bb0095 article-title: Effects of growth hormone on glucose, lipid and protein metabolism in human subjects publication-title: Endocr. Rev. doi: 10.1210/er.2008-0027 – volume: 137 start-page: 1913 year: 1996 ident: 10.1016/j.ghir.2020.101318_bb0170 article-title: Differential long-term effects of insulin-like growth factor-I (IGF-I), growth hormone (GH) and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats publication-title: Endocrinology doi: 10.1210/endo.137.5.8612531 – volume: 87 start-page: 90 year: 2002 ident: 10.1016/j.ghir.2020.101318_bb0200 article-title: Effects of dose and gender on the growth and growth factor response to gh in GH deficient children: implications for efficacy and safety publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem.87.1.8150 – volume: 261 start-page: 4828 year: 1986 ident: 10.1016/j.ghir.2020.101318_bb0020 article-title: Organization and sequence of the insulin-like growth factor 1 gene publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(19)89179-2 – volume: 19 start-page: 717 year: 1998 ident: 10.1016/j.ghir.2020.101318_bb0120 article-title: Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human publication-title: Endocr. Rev. – volume: 95 start-page: 1229 year: 2010 ident: 10.1016/j.ghir.2020.101318_bb0210 article-title: Observed and predicted growth responses in prepubertal children with growth disorders: guidance of growth hormone treatment by empirical variables publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2009-1471 – volume: 83 start-page: 280 year: 2015 ident: 10.1016/j.ghir.2020.101318_bb0050 article-title: How aggressively should we treat short stature? publication-title: Horm Res Paediatr doi: 10.1159/000374114 – volume: 3 start-page: 297 year: 1995 ident: 10.1016/j.ghir.2020.101318_bb0035 article-title: Insulin-like growth factor 1 and growth hormone have distinct and overlapping anabolic effects in GH deficient rats publication-title: Endocrine doi: 10.1007/BF03021409 – volume: 92 start-page: 902 year: 2007 ident: 10.1016/j.ghir.2020.101318_bb0180 article-title: Long-term treatment with recombinant insulin-like growth factor (IGF)-I in children wit severe IGF-I deficiency due to growth hormone insensitivity publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2006-1610 – volume: 86 start-page: 2868 year: 1989 ident: 10.1016/j.ghir.2020.101318_bb0155 article-title: Effects of insulin-like growth factor-I on insulin secretion and renal function in normal human subjects publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.86.8.2868 – volume: 92 start-page: 2480 year: 2007 ident: 10.1016/j.ghir.2020.101318_bb0195 article-title: on behalf of the American Norditropin Study Group publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2007-0204 – volume: 83 start-page: 268 year: 2015 ident: 10.1016/j.ghir.2020.101318_bb0045 publication-title: Horm Res in Paediatr doi: 10.1159/000371799 – volume: 84 start-page: 4397 issue: 12 year: 1999 ident: 10.1016/j.ghir.2020.101318_bb0065 article-title: The essential role of IGF-I: lessons from the long-term study and treatment of children and adults with Laron syndrome publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem.84.12.6255 – volume: 6 start-page: 129 year: 2017 ident: 10.1016/j.ghir.2020.101318_bb0115 article-title: A phase 2 trial of long-acting growth hormne in adult GH deficiency publication-title: Endocrine Connections doi: 10.1530/EC-17-0007 – volume: 325 start-page: 70 year: 2002 ident: 10.1016/j.ghir.2020.101318_bb0015 article-title: Adult height after long-term treatment with recombinant growth hormone for idiopathic isolated growth hormone deficiency: observational follow-up study of the French population based registry publication-title: BMJ doi: 10.1136/bmj.325.7355.70 – volume: 90 start-page: 2855 year: 2005 ident: 10.1016/j.ghir.2020.101318_bb0140 article-title: Homozygous and Heterozygous expression of a novel insulin-like growth factor-I mutation publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2004-1254 – volume: 229 start-page: 141 year: 2001 ident: 10.1016/j.ghir.2020.101318_bb0165 article-title: Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth publication-title: Dev. Biol. doi: 10.1006/dbio.2000.9975 – volume: 84 start-page: 1174 year: 1999 ident: 10.1016/j.ghir.2020.101318_bb0205 article-title: Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem.84.4.5634 – volume: 160 start-page: 349 year: 2009 ident: 10.1016/j.ghir.2020.101318_bb0110 article-title: Pharmacokinetic and pharmacodynamic profile of a new sustained release GH formulation, LB3002, in children with GH deficiency publication-title: Eur. J. Endocrinol. doi: 10.1530/EJE-08-0703 – volume: 65 start-page: 1075 year: 1987 ident: 10.1016/j.ghir.2020.101318_bb0090 article-title: On the nomenclature of the somatomedins and insulin-like growth factors publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem-65-5-1075 – volume: 16 start-page: 3 year: 1995 ident: 10.1016/j.ghir.2020.101318_bb0215 article-title: Insulin-like growth factors and their binding proteins: biological actions publication-title: Endocr. Rev. – volume: 91 start-page: 2047 year: 2006 ident: 10.1016/j.ghir.2020.101318_bb0010 article-title: Effect of growth hormone treatment in the near-final height of 1258 patients with idiopathic GH deficiency: analysis of a large international database publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2005-2284 – volume: 77 start-page: 273 year: 1993 ident: 10.1016/j.ghir.2020.101318_bb0125 article-title: Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome publication-title: J. Clin. Endocrinol. Metab. – volume: 368 start-page: 1220 year: 2013 ident: 10.1016/j.ghir.2020.101318_bb0055 article-title: Short stature in childhood- challenges and choices publication-title: N. Engl. J. Med. doi: 10.1056/NEJMcp1213178 – volume: 9 start-page: 11 year: 2007 ident: 10.1016/j.ghir.2020.101318_bb0150 article-title: Therapeutic aspects of growth hormone and insulin-like growth factor_I treatment on visceral fat and insulin sensitivity in adults diabetes publication-title: Obes. Metab. doi: 10.1111/j.1463-1326.2006.00591.x – volume: 368 start-page: 612 year: 2006 ident: 10.1016/j.ghir.2020.101318_bb0030 article-title: Is there a role for recombinant insulin-like growth factor 1 in the treatment of idiopathic short stature? publication-title: Lancet doi: 10.1016/S0140-6736(06)69205-2 – volume: 15 start-page: 369 issue: 3 year: 1994 ident: 10.1016/j.ghir.2020.101318_bb0070 article-title: Guevarra-Aguirre J growth hormone (GH) insensitivity due to primary GH receptor deficiency publication-title: Endocr. Rev. doi: 10.1210/edrv-15-3-369 – volume: 7 start-page: 34 year: 2015 ident: 10.1016/j.ghir.2020.101318_bb0100 article-title: Growth hormone bioavailability, insulin-like growth factor-I and IGF-binding protein 3 release in Japanese and Caucasian subjects publication-title: Bioequivalence and Bioavailabilty – volume: 85 start-page: 1686 year: 2000 ident: 10.1016/j.ghir.2020.101318_bb0130 article-title: Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid and calcium metabolism publication-title: J. Clin. Endocrinol. Metab. – volume: 10 start-page: 611 issue: 95 year: 2011 ident: 10.1016/j.ghir.2020.101318_bb0160 article-title: Recombinant insulin-like growth factor-I (IGF_I) treatment in short children with low IGF-I levels: First year results from a randomized clinical trial publication-title: J Clin Endocrinol Metab – volume: 49 start-page: 825 year: 1957 ident: 10.1016/j.ghir.2020.101318_bb0085 article-title: A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro publication-title: J. Lab. Clin. Med. – volume: xxx start-page: 353 year: 1945 ident: 10.1016/j.ghir.2020.101318_bb0080 article-title: Isolation and properties of the anterior hypophyseal growth hormone publication-title: J. Biol Chem doi: 10.1016/S0021-9258(19)52796-X – volume: 124 start-page: 2519 year: 1989 ident: 10.1016/j.ghir.2020.101318_bb0175 article-title: Growth responses in a mutant dwarf rat to human growth hormone and recombinant human insulin-like growth factor-I publication-title: Endocrinology doi: 10.1210/endo-124-5-2519 |
| SSID | ssj0009384 |
| Score | 2.259939 |
| SecondaryResourceType | review_article |
| Snippet | Both rhGH and rhIGF-I are signaling molecules with the capacity to restore the rate of growth in certain subsets of slowly growing children. In some instances,... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 101318 |
| Title | A rationale for the treatment of short stature in children with the combination of recombinant human growth hormone (rhGH) and recombinant human insulin-like growth factor-I (rhIGF-I) |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1096637420300277 https://dx.doi.org/10.1016/j.ghir.2020.101318 https://www.ncbi.nlm.nih.gov/pubmed/32252003 https://www.proquest.com/docview/2387260105 |
| Volume | 52 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3daxQxEA-lgvgi2vpxfpQRRCwS73az2b17PA6vd2qLqIW-hXz2Vuu2XO8efPHf8t9zJps9EWoFn5YNM9mQmZ38JpnJMPa8JB8iqzQ3WQi80MFyrTPDndBuFKjkaqxacnhUzo6LtyfyZItNulwYCqtMtr-16dFap5Z-ms3-RV33P2WIvkuBrh3qKZ1EUgZ7UZGWv_7xO8xjJGLVYSLmRJ0SZ9oYr9NFTXeC5rFBUOGPqxenv4HPuAhN77DbCT3CuB3gXbblmx22O27Qc_72HV5AjOeMG-U77OZhOjbfZT_HsEybfh4QpQKiPtiEmMN5gMsFwnCg7KL10kPdQJfkDbRRG-lxhtCLjt0QB3nSsQE7iIX-4BQ9eqTFnlC1PbxcLg5m-6AbdwVtCoHnZ_VX3zG2pX_4nDjnB1M-37_HjqdvPk9mPFVs4BYdwxWXWnrjUPrWh2EpbK4RvA_McGArEaT0oyCCNjILVWWsdha9NWtF7vIhiscPnLjPthsc4kMGxmTeigI9aKuLHNXHu8r50ssgi1DqqseyTlTKpuvMqarGmeri1r4oEq8i8apWvD32asNz0V7mcS216DRAdWmqaFgVrjXXcskN1x-K_E--Z52SKfzD6dhGN_58fakQVFV08dtA9tiDVvs2oydzTOGFj_7zq4_ZLXprY9-esO3Vcu2fIspamb34G-2xG-PJx_cf6Dl_Nzv6BdQfKhU |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGkIAXBBsf5dNIgJiQaRPHSfvAQwV0DVv3wibtzdiOvQZGOqWtpr3wT_HAv8ed4xQhjSEh7dXxOSff-Xxn_85HyPMUY4goU0xHzrFEOcOUijQruCoGDkuu-qolk710fJB8PBSHa-RHmwuDsMpg-xub7q11aOmG2eyelGX3UwTed8ohtAM9xZvIgKzcsWenELfN3-bvQcgv4nj0Yf_dmIXSAsxABLNgQgmrC2DTWNdPuYkVeJk93e-ZjDsh7MBxp7SIXJZpowoDYYUxPC7iPvzU9goO414hVxMwF1g24c3337iSAfdljpE7huyFTJ0GVHY0LfER0tg3cKw0cv5u-Ddv1-96o1vkZnBX6bCZkdtkzVYbZHNYQaj-7Yy-pB5A6k_mN8i1Sbin3yQ_h7QOp4yWgltMwc2kK0w7nTk6n4LfTzGdaVlbWla0zSqneDLs-4NIIGz3wyAFhu6-AQbwlQXpUT07hb4wEqwlS1_V0-3xFlVVcU7fgLlnx-VX2xI2tYZYjpT59ojlW3fIwaXI8S5Zr4DF-4RqHVnDEwjZjUpi0FdbZIVNrXAicanKOiRqRSVNeD8dy3gcyxYo90WieCWKVzbi7ZDXK5qT5vWQC3vzVgNkmxcLllzC5nYhlVhR_bFy_kn3rFUyCSYF74lUZWfLuQQvLsOX5nqiQ-412rfiHu0_4hkf_Odfn5Lr4_3JrtzN93Yekhv4pQHePSLri3ppH4OLt9BP_JKi5PNlr-FfGU1lYA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+rationale+for+the+treatment+of+short+stature+in+children+with+the+combination+of+recombinant+human+growth+hormone+%28rhGH%29+and+recombinant+human+insulin-like+growth+factor-I+%28rhIGF-I%29&rft.jtitle=Growth+hormone+%26+IGF+research&rft.au=Bright%2C+George+M&rft.au=Fierro-Renoy%2C+Juan+Francisco&rft.date=2020-06-01&rft.issn=1532-2238&rft.eissn=1532-2238&rft.volume=52&rft.spage=101318&rft_id=info:doi/10.1016%2Fj.ghir.2020.101318&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1096-6374&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1096-6374&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1096-6374&client=summon |